Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia

NCT01900522 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

76

Enrollment

INDUSTRY

Sponsor class

Stopped Business Decision; No Safety or Efficacy Concerns

Conditions

Schizophrenia

Interventions

DRUG: ITI-214 Dose A
DRUG: ITI-214 Dose B
DRUG: ITI-214 Dose C
DRUG: ITI-214 Dose D (Elderly)
DRUG: Placebo
DRUG: ITI-214 Dose E
DRUG: ITI-214 Dose F
DRUG: ITI-214 Dose G
DRUG: ITI-214 Dose H
DRUG: Placebo

Sponsor

Takeda

Collaborators

[object Object]